Measures to improve early results in kidney transplantation.
Schweizer
R T
RT
Hartford Transplant Center, Hartford Hospital, CT 06115.
Roper
L
L
Hull
D
D
Bartus
S
S
D000212:Acyclovir / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000009:adverse effects; D002423:Cause of Death; D003022:Clotrimazole / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000009:adverse effects; D009894:Opportunistic Infections / Q000188:drug therapy / Q000401:mortality; D010419:Pentamidine / Q000008:administration & dosage; D011183:Postoperative Complications / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality; D016019:Survival Analysis; D015996:Survival Rate; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003022:Clotrimazole; D000212:Acyclovir